Vivus Says Ch. 11 Plan Should Be OK'd Despite Opposition
Biopharmaceutical venture Vivus Inc. told the Delaware bankruptcy court Tuesday its Chapter 11 plan should be approved despite opposition from the federal bankruptcy watchdog and others because it is a "value-maximizing"...To view the full article, register now.
Already a subscriber? Click here to view full article